Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Essen Biotech
University of Nebraska
Adela, Inc
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Incyte Corporation
University of Colorado, Denver
University of Alabama at Birmingham
University of Alberta
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Taproot Health
University of Modena and Reggio Emilia
University of Rochester
Stanford University
Cedars-Sinai Medical Center
Sanguine Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
OHSU Knight Cancer Institute
Weprom
Celgene
GlaxoSmithKline
Celgene
InSightec
University of Wisconsin, Madison
LEO Pharma
AbbVie
SWOG Cancer Research Network
CureOne
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Wake Forest University Health Sciences
Novartis
M.D. Anderson Cancer Center
Sandoz
Stanford University
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
Amgen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Bayer
Bayer
Novartis